...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Annual and Special Mtg & Corporate Update Presentation 12/22/20 - Rough Transcript

bang on NB - lots of Why's & Whens - that seems to be where we have been for far to long now - im happy chilling for 3-6 months hoping my expectations & dreams don't turn into nightmares.

Donny talks alot - time for him to bring it home or leave the dance floor IMO & yes i believe a Zen deal would help to pop RVX as well.

Share
New Message
Please login to post a reply